Photo by nci from unsplash
Valsartan is safe and effective in improving cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from the phase II VANISH trial. Click to show full abstract
Valsartan is safe and effective in improving cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from the phase II VANISH trial.
Keywords:
valsartan attenuates;
patients hcm;
remodelling patients;
cardiac dysfunction;
attenuates cardiac;
dysfunction remodelling
Journal Title: Nature Reviews Cardiology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Nature Reviews Cardiology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!